| Serial Number | 79350535 |
| Word Mark | ALEVATE |
| Filing Date | Tuesday, May 17, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 3, 2024 |
| Registration Number | 7582839 |
| Registration Date | Tuesday, December 3, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 1, 2024 |
| Goods and Services | Education, namely, classes, seminars, and workshops in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; providing of training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; teaching and training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccines, growth factors, immune modulators, monoclonal antibodies, cells, cell therapies, tissues, proteins, recombinant proteins, nucleic acids, gene therapies, products derived from living culture systems, products derived from human blood, products derived from plasma; provision of medical, biological, biopharmaceutical, pharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medical, biological, biopharmaceutical, pharmaceutical and chemical research and development; technical training in the field of medical, biological, biopharmaceutical, pharmaceutical and chemical analysis; information, consultancy and advisory services for the aforementioned services |
| Goods and Services | Regulatory compliance auditing; regulatory compliance consultancy in the field of biotechnology, pharmaceuticals, biopharmaceuticals, and medical testing and research; reviewing standards and practices to assure compliance with laws and regulations in the fields of biology, pharmaceuticals, biopharmaceuticals, chemicals, and medicine; information, consultancy and advisory services for the aforementioned services |
| Goods and Services | Research and development services in the field of new biological, pharmaceutical, biopharmaceutical, chemical and medical products; technological consultancy, namely, providing consultancy and expert assistance in the field of new product development of medicines and pharmaceutical products, and laboratory analysis in the field of medicines and pharmaceuticals; research, development and laboratory analysis services relating to pharmaceutical and medicinal goods, in particular, albumin, chemicals, peptides, proteins, antibodies, cells, nucleic acids, viruses, live viruses, live-attenuated viruses, attenuated viruses, virus-like particles and viral vectors; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality control services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, quality assurance in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; quality control services for others in the field of development and testing of cells; services of a scientific chemical and biological laboratory; development and testing of chemical, pharmaceutical, biopharmaceutical, chemical, and medical production methods; quality control services for others and authentication services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, providing quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; scientific and medical laboratory services; information, consultancy and advisory services for research, testing, and development in the pharmaceutical, biopharmaceutical, chemical, and medical fields, none of the foregoing related to financial software |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 23, 2022 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 23, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 23, 2022 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Albumedix Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Albumedix Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Albumedix Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Friday, September 23, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 22, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, September 27, 2022 | APPLICATION FILING RECEIPT MAILED |
| Sunday, January 29, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, March 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, March 15, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, March 16, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, April 2, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, May 4, 2023 | REFUSAL PROCESSED BY MPU |
| Thursday, May 4, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, May 24, 2023 | REFUSAL PROCESSED BY IB |
| Friday, November 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 3, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, December 31, 2023 | FINAL REFUSAL WRITTEN |
| Sunday, December 31, 2023 | FINAL REFUSAL E-MAILED |
| Sunday, December 31, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, February 28, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, February 28, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, March 18, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, June 24, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, June 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 28, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 1, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 1, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 3, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 3, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Monday, March 3, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |